Substance-impacted perinatal women; granting certain immunity from prosecution; authorizing certain action by district attorney. Effective date.
SB2002 creates a new statutory framework for “substance-impacted perinatal women,” defined as biological women who used a controlled dangerous substance during pregnancy or within 12 months after the pregnancy ended. The bill allows health care providers to recommend enrollment in a qualified addiction recovery or behavioral health program when they identify repeated use of alcohol or unprescribed controlled substances, and it provides immunity from prosecution in certain circumstances tied to pregnancy-based conduct.
The bill generally bars investigation, arrest, or prosecution solely for lawful prescription drug use, and also bars prosecution when a woman is already enrolled in, or making a good-faith effort to enroll in, a qualified program but faces barriers such as lack of treatment capacity. It specifically extends this protection to situations involving miscarriage, stillbirth, or an infant showing signs of Neonatal Abstinence Syndrome or Fetal Alcohol Spectrum Disorder when the conduct is tied to alcohol or prescribed controlled substances. If the woman does not make a good-faith effort to enroll in or complete treatment, the district attorney may pursue an appropriate disposition under existing law.
SB2002 also grants civil immunity to health care providers who do not know and could not reasonably have known about substance use, or who act in accordance with the bill’s referral and reporting provisions. At the same time, the bill preserves the ability to investigate and prosecute child abuse, neglect, or endangerment unrelated to pregnancy-based conduct, preserves parental-rights actions unrelated to that conduct, and does not alter the duty to report a substance-exposed newborn.
The bill amends existing law governing district attorney multidisciplinary teams for pregnant women abusing drugs or alcohol by clarifying that an appropriate disposition may include involuntary commitment and by requiring team membership to include someone with training and experience in treating addiction and pregnant women. In practical terms, the bill would modify Oklahoma criminal, child welfare, and health-care-related procedures affecting pregnant and postpartum women with substance use issues, while also shaping how district attorneys and medical providers respond to these cases.
The available context shows no recorded votes or committee transcript discussion, so sentiment cannot be measured from debate history. Based on the bill text, the measure appears aimed at treatment-oriented intervention and limiting prosecution in specified circumstances, while still preserving enforcement tools for cases where treatment is refused or where unrelated child abuse or neglect is alleged.
SB2002 would add a new section to Title 63 and amend Section 1-546.5 governing district attorney multidisciplinary teams. It would create statutory immunity from investigation, arrest, or prosecution in certain pregnancy-related substance use situations, establish civil immunity for health care providers acting in good faith, and preserve mandatory newborn reporting obligations under Title 10A. It would also expand and clarify the role of multidisciplinary teams and the range of possible dispositions, including involuntary commitment, for pregnant women abusing drugs or alcohol.
There is no committee transcript or vote history available in the provided materials, so there is no direct evidence of support or opposition from legislative debate. The bill’s structure suggests a generally treatment-focused and harm-reduction approach, with protections for women seeking or receiving care and continued authority for prosecutors when treatment is refused. Overall, the measure appears designed to balance public health intervention with criminal enforcement, but the absence of recorded discussion prevents a more specific assessment of sentiment.
The main points of potential contention are the scope of immunity from prosecution, the bill’s definition of pregnancy-based conduct, and the balance between treatment and criminal accountability. Supporters are likely to favor the bill’s protections for women who are prescribed medication, are in treatment, or face barriers to accessing care, as well as the civil immunity for providers. Opponents may focus on the limits of the immunity, the continued role of district attorneys, and whether the bill sufficiently addresses child safety and accountability in cases involving substance use during pregnancy.